GlycoMimetics Inc
$ 0.16
0.00%
03 Mar - close price
- Market Cap 10,131,500 USD
- Current Price $ 0.16
- High / Low $ 15.70 / 0.16
- Stock P/E N/A
- Book Value 5.23
- EPS -46.00
- Next Earning Report -
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.74 %
- ROE -1.83 %
- 52 Week High 18.40
- 52 Week Low 0.15
About
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of new glucomimetic drugs to address unmet medical needs resulting from disease in the United States. The company is headquartered in Rockville, Maryland.
Analyst Target Price
$1.00
Quarterly Earnings
| Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-07-30 | 2025-05-07 | 2025-03-25 | 2024-11-01 | 2024-08-01 | 2024-05-06 | 2024-03-27 | 2023-11-03 | 2023-08-02 | 2023-05-03 | 2023-03-29 | 2022-11-09 |
| Reported EPS | 0 | -0.04 | -0.112 | -0.15 | -0.16 | -0.17 | -0.14 | -0.14 | -0.13 | -0.17 | -0.19 | -0.16 |
| Estimated EPS | 0 | -0.05 | -0.09 | -0.11 | -0.17 | -0.16 | -0.15 | -0.14 | -0.18 | -0.17 | -0.17 | -0.26 |
| Surprise | 0 | 0.01 | -0.022 | -0.04 | 0.01 | -0.01 | 0.01 | 0 | 0.05 | 0 | -0.02 | 0.1 |
| Surprise Percentage | None% | 20% | -24.4444% | -36.3636% | 5.8824% | -6.25% | 6.6667% | 0% | 27.7778% | 0% | -11.7647% | 38.4615% |
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
